Change one atom and the drug may stop working. That is the lesson of structure-activity relationships, the study of how a molecule's structure affects its biological activity. Medicinal chemists use SAR to guide their modifications. If adding a methyl group to a certain position increases potency, they try adding other groups there. If removing a hydroxyl group reduces toxicity, they look for other changes that have the same effect. The goal is to find the structural features that matter and optimize them.

SAR is built from testing. Chemists synthesize a series of related compounds, each with a small structural change, and measure their activity. The data are plotted or tabulated, and patterns emerge. Quantitative SAR, or QSAR, takes it further by building mathematical models that predict activity from molecular properties. These models can screen virtual libraries before any compound is made. SAR is not always simple. A change that improves potency may worsen solubility, or a modification that reduces toxicity may also reduce efficacy. The chemist balances multiple properties at once.

What SAR reveals:

• Pharmacophore. The structural features required for activity.
• Potency trends. How changes affect the dose needed for effect.
• Selectivity. How changes affect binding to related targets.
• Metabolic stability. How changes affect breakdown by the body.
• Toxicity. How changes affect safety.

SAR is iterative. Each round of design, synthesis, and testing informs the next.